Home / Inspections / 1017306

FDA Inspection 1017306 — Cooper Institute for Advanced Reproductive Medicine

Cooper Institute for Advanced Reproductive Medicine — FEI 3011006339

The FDA completed an inspection of Cooper Institute for Advanced Reproductive Medicine on April 26, 2017 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1223634 (OAI Thu Nov 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1192782 (NAI Fri Dec 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1146456 (OAI Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 907753 (VAI Mon Dec 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources